WO1990006116A2 - Mittel zur behandlung von chronisch entzündlichen darmerkrankungen - Google Patents
Mittel zur behandlung von chronisch entzündlichen darmerkrankungen Download PDFInfo
- Publication number
- WO1990006116A2 WO1990006116A2 PCT/EP1989/001426 EP8901426W WO9006116A2 WO 1990006116 A2 WO1990006116 A2 WO 1990006116A2 EP 8901426 W EP8901426 W EP 8901426W WO 9006116 A2 WO9006116 A2 WO 9006116A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- oxipurinol
- alkaline earth
- contain
- ammonium salts
- composition according
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Abstract
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT89912949T ATE85522T1 (de) | 1988-11-25 | 1989-11-24 | Mittel zur behandlung von chronisch entzuendlichen darmerkrankungen. |
DE8989912949T DE58903550D1 (de) | 1988-11-25 | 1989-11-24 | Mittel zur behandlung von chronisch entzuendlichen darmerkrankungen. |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DEP3839839.7 | 1988-11-25 | ||
DE3839839A DE3839839A1 (de) | 1988-11-25 | 1988-11-25 | Mittel zur behandlung von chronisch entzuendlichen darmerkrankungen |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1990006116A2 true WO1990006116A2 (de) | 1990-06-14 |
WO1990006116A3 WO1990006116A3 (de) | 1990-08-23 |
Family
ID=6367891
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP1989/001426 WO1990006116A2 (de) | 1988-11-25 | 1989-11-24 | Mittel zur behandlung von chronisch entzündlichen darmerkrankungen |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0445156B1 (de) |
JP (1) | JP2686566B2 (de) |
DE (2) | DE3839839A1 (de) |
ES (1) | ES2054097T3 (de) |
WO (1) | WO1990006116A2 (de) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003002567A1 (en) * | 2001-06-28 | 2003-01-09 | Astrazeneca Ab | New pyrazolo[3,4-d]pyrimidines inhibiting h. pylori infections |
WO2004056831A1 (en) * | 2002-12-20 | 2004-07-08 | Astrazeneca Ab | PYRAZOLO [3,4-d] PYRIMIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF H.PYLORI INFECTION |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006083687A1 (en) * | 2005-01-28 | 2006-08-10 | Cardiome Pharma Corp. | Crystal salt of xanthine oxidase inhibitors |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB975850A (en) * | 1955-08-10 | 1964-11-18 | Wellcome Found | Xanthine oxidase inhibitors |
AT352686B (de) * | 1976-03-23 | 1979-10-10 | Spiegl Paul Dr | Verfahren zur herstellung von mikrokapseln |
EP0062000A2 (de) * | 1981-03-18 | 1982-10-06 | Stafford-Miller Continental | Verwendung von 4-Aminosalicylsäure als entzündungshemmender Wirkstoff |
EP0261439A2 (de) * | 1986-08-28 | 1988-03-30 | Mect Corporation | Arzneimittel zur Heilung von Arteriosklerose, enthaltend ein Pyrimido(2,1-b)benzothiazol-Derivat |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU599085B2 (en) * | 1986-03-13 | 1990-07-12 | Wellcome Foundation Limited, The | Cell protection |
-
1988
- 1988-11-25 DE DE3839839A patent/DE3839839A1/de active Granted
-
1989
- 1989-11-24 DE DE8989912949T patent/DE58903550D1/de not_active Expired - Fee Related
- 1989-11-24 WO PCT/EP1989/001426 patent/WO1990006116A2/de active IP Right Grant
- 1989-11-24 ES ES89912949T patent/ES2054097T3/es not_active Expired - Lifetime
- 1989-11-24 EP EP89912949A patent/EP0445156B1/de not_active Expired - Lifetime
- 1989-11-24 JP JP2500188A patent/JP2686566B2/ja not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB975850A (en) * | 1955-08-10 | 1964-11-18 | Wellcome Found | Xanthine oxidase inhibitors |
AT352686B (de) * | 1976-03-23 | 1979-10-10 | Spiegl Paul Dr | Verfahren zur herstellung von mikrokapseln |
EP0062000A2 (de) * | 1981-03-18 | 1982-10-06 | Stafford-Miller Continental | Verwendung von 4-Aminosalicylsäure als entzündungshemmender Wirkstoff |
EP0261439A2 (de) * | 1986-08-28 | 1988-03-30 | Mect Corporation | Arzneimittel zur Heilung von Arteriosklerose, enthaltend ein Pyrimido(2,1-b)benzothiazol-Derivat |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003002567A1 (en) * | 2001-06-28 | 2003-01-09 | Astrazeneca Ab | New pyrazolo[3,4-d]pyrimidines inhibiting h. pylori infections |
US7285558B2 (en) | 2001-06-28 | 2007-10-23 | Astrazeneca Ab | Pyrazolo[3,4-d]pyrimidines inhibiting H. pylori infections |
WO2004056831A1 (en) * | 2002-12-20 | 2004-07-08 | Astrazeneca Ab | PYRAZOLO [3,4-d] PYRIMIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF H.PYLORI INFECTION |
Also Published As
Publication number | Publication date |
---|---|
DE3839839C2 (de) | 1991-12-19 |
JPH04502005A (ja) | 1992-04-09 |
EP0445156B1 (de) | 1993-02-10 |
JP2686566B2 (ja) | 1997-12-08 |
EP0445156A1 (de) | 1991-09-11 |
ES2054097T3 (es) | 1994-08-01 |
WO1990006116A3 (de) | 1990-08-23 |
DE3839839A1 (de) | 1990-05-31 |
DE58903550D1 (de) | 1993-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0032562B1 (de) | Neue Dipyridamol-Retardformen und Verfahren zu ihrer Herstellung | |
EP0208971B1 (de) | Feste Arzneimittelformen zur peroralen Anwendung enthaltend 9-Deoxo-11-deoxy-9,11-(imino(2-(2-methoxyethoxy)ethyliden)-oxy)-(9S)-erythromycin und Verfahren zu ihrer Herstellung | |
DE69726015T2 (de) | Pharmazeutische zusammensetzung enthaltend koenzym q-10 | |
DE60026144T2 (de) | Benzamidformulierung mit histon-deacetylase-inhibitoraktivität | |
AT396329B (de) | Pharmazeutische granulate und verfahren zu ihrer herstellung | |
DE19732903A1 (de) | Pellet-Formulierung zur Behandlung des Intestinaltraktes | |
DE3024858A1 (de) | Anhaltend freigebende pharmazeutische zubereitung eines festen medikamentmaterials | |
WO1995008323A1 (de) | Budesonid-pellets mit kontrolliertem freigabeprofil und verfahren zu ihrer herstellung | |
WO1998000115A2 (de) | Stabile arzneiform zur oralen verabreichung und verfahren zu ihrer herstellung | |
DE2351412C2 (de) | 2,2-Disubstituierte 1-Oxo-5-indanyloxy-carbonsäuren, Verfahren zu deren Herstellung und Spaltung racemischer Gemische, sowie diese enthaltende Arzneimittel | |
DE60006362T2 (de) | Kapseln mit loratadin und pseudoephedrin enthaltenden zusammensetzungen | |
DD267490A5 (de) | Verfahren zur herstellung von wasserfreiem, kristallinem natriumsalz von 5-chlor-3-(2-thenoyl)-2-odindol-1-carboxamid | |
DE2218147C2 (de) | Pharmazeutische Zubereitung | |
CH654004A5 (de) | Kristallmodifikationen des monohydrats und der wasserfreien form von (+)-catechin, verfahren zu deren herstellung und die sie enthaltenden pharmazeutischen zusammensetzungen. | |
DE10153934A1 (de) | Verfahren zur Kristallisation von Profenen | |
CH658787A5 (de) | Pharmazeutische praeparate mit gleichbleibenden elutionseigenschaften. | |
DE60110118T2 (de) | Kristalline glukosaminsulfatmetallsalze und verfahren zu deren herstellung | |
DE3839839C2 (de) | ||
DE19906290A1 (de) | Arzneimittel zur Behandlung bzw. Prävention von Darmkrebs | |
DE19850445A1 (de) | Arzneimittel zur topischen Behandlung entzündlicher Darmerkrankungen | |
DE3830563A1 (de) | Orale magnesium und kalium enthaltende praeparate und deren verwendung | |
EP0130549B1 (de) | 5-Aminosalicylsäure-O-sulfate von physiologisch unbedenklichen Basen, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel | |
AT412447B (de) | Mittel mit zerstörender wirkung auf maligne tumore sowie verfahren zu seiner herstellung | |
DE3031788A1 (de) | Verwendung von sesquiterverbindungen zur herstellung von arzneimitteln zur prophylaxe und therapie von haepatitis | |
EP0308665B1 (de) | Salze der 5-Aminosalicylsäure und sie enthaltende Arzneimittelzubereitungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE ES FR GB IT LU NL SE |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE ES FR GB IT LU NL SE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1989912949 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1989912949 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 1989912949 Country of ref document: EP |